Literature DB >> 23196270

Asthma outcomes revisited.

Amit D Parulekar1, Ammar Alobaidy, Nicola A Hanania.   

Abstract

PURPOSE OF REVIEW: Asthma outcomes constitute the cornerstone of asthma clinical research. Despite their known importance, it has been difficult for researchers to standardize these outcomes in large part because of the heterogeneity of the disease. This review seeks to provide an overview of recent recommendations for standardization of asthma outcomes in clinical trials, as well as discuss areas of future interest. RECENT
FINDINGS: Several outcome measures have been recommended and are used in evaluating different interventions in asthma clinical trials. Such outcomes include lung function, asthma control measures, symptoms, exacerbations, quality of life, biomarkers, healthcare utilization and cost of care. More recently, recommendations for core measures, supplemental measures and future areas of interest for all future asthma clinical trials have been recommended by the Asthma Outcomes Workshop supported by the National Institute of Health (NIH) and the Agency for Healthcare Research and Quality (AHRQ) in the US.
SUMMARY: Standardization of asthma outcomes allows the comparison of results across multiple studies and centers. The recommendations of the Asthma Outcomes Workshop constitute an excellent first step in standardizing the way in which asthma outcomes are assessed. The asthma research community is now charged with implementing these recommendations and expanding upon them.

Mesh:

Year:  2013        PMID: 23196270     DOI: 10.1097/MCP.0b013e32835b11f6

Source DB:  PubMed          Journal:  Curr Opin Pulm Med        ISSN: 1070-5287            Impact factor:   3.155


  3 in total

1.  The impact of OHIP+ pharmacare on use and costs of public drug plans among children and youth in Ontario: a time-series analysis.

Authors:  Benard N Miregwa; Anne Holbrook; Michael R Law; John N Lavis; Lehana Thabane; Lisa Dolovich; Michael G Wilson
Journal:  CMAJ Open       Date:  2022-09-27

2.  Comparative effectiveness of inhaled corticosteroids for paediatric asthma: protocol for a systematic review and Bayesian network meta-analysis.

Authors:  Masato Takeuchi; Hirotsugu Kano; Kenzo Takahashi; Tsutomu Iwata
Journal:  BMJ Open       Date:  2015-10-22       Impact factor: 2.692

3.  Clinical Interpretation of Efficacy Outcomes in Pharmacological Studies on Triple Fixed-Dose Combination Therapy for Uncontrolled Asthma: Assessment of IRIDIUM and ARGON Studies.

Authors:  Paola Rogliani; Luigino Calzetta
Journal:  J Exp Pharmacol       Date:  2022-01-11
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.